DEA Agrees to Reschedule Marijuana From Schedule I to Schedule III
Key Takeaway
The US Drug Enforcement Administration formally circulated a proposal to reclassify marijuana from Schedule I to Schedule III of the Controlled Substances Act, the most significant federal cannabis policy change in 50 years. The proposal, based on the HHS recommendation from August 2023, would officially recognize cannabis's medical value, allow cannabis businesses to deduct ordinary expenses under Section 280E, and remove certain research barriers that had limited cannabis studies for decades. The move did not legalize cannabis but would fundamentally change the tax economics of state-legal cannabis businesses. For cannabis operators, the DEA's agreement to advance rescheduling represented a long-awaited federal breakthrough after years of procedural stalling.
What This Means for Cannabis Businesses
Federal policy changes ripple across the entire cannabis industry. Whether it's rescheduling progress, banking legislation, or court rulings, these developments shape the operating environment for businesses in every legal state. Operators should monitor these developments closely and consult with their legal counsel to understand the implications for their specific markets and operations.
Related Guides
Find Help
Related News
Congressman Presses DOJ and DEA on Cannabis Rescheduling Timeline
New Congressional Research Report on Cannabis Rescheduling Published
Congressional Research Service Releases Comprehensive Cannabis Rescheduling Report
Federal Government Warns About Cannabis and Hemp in Drug Tests
This analysis is based on reporting by Marijuana Moment. Read the original article. CannaBizGuide provides original commentary and analysis - this is not legal or tax advice.